Bayer AG (BAYZF)
62.48
+0.28
(+0.45%)
USD |
OTCM |
Nov 13, 16:00
Bayer Price to Book Value : 1.852 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.852 |
| November 12, 2026 | 1.844 |
| November 11, 2026 | 1.882 |
| November 10, 2026 | 1.878 |
| November 09, 2026 | 1.885 |
| November 06, 2026 | 1.794 |
| November 05, 2026 | 1.848 |
| November 04, 2026 | 1.791 |
| November 03, 2026 | 1.737 |
| November 02, 2026 | 1.653 |
| October 30, 2026 | 1.653 |
| October 29, 2026 | 1.551 |
| October 28, 2026 | 1.522 |
| October 27, 2026 | 1.499 |
| October 26, 2026 | 1.510 |
| October 23, 2026 | 1.464 |
| October 22, 2026 | 1.464 |
| October 21, 2026 | 1.464 |
| October 20, 2026 | 1.464 |
| October 19, 2026 | 1.447 |
| October 16, 2026 | 1.473 |
| October 15, 2026 | 1.482 |
| October 14, 2026 | 1.453 |
| October 13, 2026 | 1.453 |
| October 12, 2026 | 1.448 |
| Date | Value |
|---|---|
| October 09, 2026 | 1.454 |
| October 08, 2026 | 1.423 |
| October 07, 2026 | 1.498 |
| October 06, 2026 | 1.498 |
| October 05, 2026 | 1.467 |
| October 02, 2026 | 1.565 |
| October 01, 2026 | 1.483 |
| September 30, 2026 | 1.636 |
| September 29, 2026 | 1.608 |
| September 28, 2026 | 1.673 |
| September 25, 2026 | 1.646 |
| September 24, 2026 | 1.634 |
| September 23, 2026 | 1.649 |
| September 22, 2026 | 1.644 |
| September 21, 2026 | 1.630 |
| September 18, 2026 | 1.598 |
| September 17, 2026 | 1.638 |
| September 16, 2026 | 1.638 |
| September 15, 2026 | 1.668 |
| September 14, 2026 | 1.668 |
| September 11, 2026 | 1.641 |
| September 10, 2026 | 1.641 |
| September 09, 2026 | 1.641 |
| September 08, 2026 | 1.641 |
| September 04, 2026 | 1.641 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck KGaA | 2.084 |
| Breakthrough Chemistry, Inc. | 1.592 |
| Cardiac Biotech Solutions, Inc. | -- |
| Fresenius SE & Co. KGaA | 1.431 |
| Carl Zeiss Meditec AG | 3.516 |
Price to Book Value Related Metrics
| PS Ratio | 1.154 |
| PEG Ratio | -0.0958 |
| Price | 62.48 |
| Earnings Yield | -2.70% |
| Market Cap | 61.38B |
| PEGY Ratio | -0.0957 |
| Operating PE Ratio | 9.155 |
| Normalized PE Ratio | 34.63 |